Clinical Trial Update: Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the safety, tolerability, and efficacy of Inclisiran in children with homozygous familial hypercholesterolemia. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia

Drugs mentioned

• Inclisiran (inclisiran)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Familial Hypercholesterolemia - Homozygous | Phase 3 | Status: RECRUITING